                         SEQUENCE LISTING

<110>  AiCuris GmbH & Co. KG
 
<120>  NOVEL INDOLIZINE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B 
       VIRUS (HBV)

<130>  A75282WO

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Antisense primer HBV

<400>  1
tgcagaggtg aagcgaagtg caca                                              24


<210>  2
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Sense primer HBV

<400>  2
gacgtccttt gtttacgtcc cgtc                                              24


<210>  3
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Hybprobe FL HBV

<400>  3
acggggcgca cctctcttta cgcgg                                             25


<210>  4
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Hybprobe PH HBV

<400>  4
ctccccgtct gtgccttctc atctgc                                            26


<210>  5
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  HBV forward primer

<400>  5
ctgtaccaaa ccttcggacg g                                                 21


<210>  6
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  HBV reverse primer

<400>  6
aggagaaacg ggctgaggc                                                    19


<210>  7
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  FAM-labelled probe for HBV

<400>  7
ccatcatcct gggctttcgg aaaatt                                            26


